(New York) Pfizer Laboratory boss on Monday promised a version of the Kovid-19 vaccine that would be ready in March if needed, in line with the Omicron variant, but talked about making a similar vaccine for his counter ‘fall’ in Moderna. .
“I do not know if we need it, I do not know how it will be used, but we will be ready. The factory has already started production, ”Albert Bourla told the US financial channel CNBC.
He pointed out in late November that his company had already started working on a new version of the vaccine targeting Omicron.
“We especially hope to be able to provide a product that provides better protection against infections, because if you have a third dose, hospitalization with current vaccines and protection from serious cases is very reasonable,” Mr. Bourla explained. On Monday ..
However, he said more studies are needed to find out whether a fourth dose is needed.
Moderna’s managing director, Stefan Bansal, suggested that his laboratory work on a booster dose for this fall, which targeted Omicron, which should enter the clinical trial “soon”.
“We are currently in talks with health officials around the world to find out what the best strategy is for a potential recall for the fall of 2022,” he told CNBC.
“We think it contains omicran,” he said, adding that other elements could also be included.
“We have to be careful not to take the virus one step further and not lag behind,” said the modern boss.
About The Author
